Research by: J.S. Gill(1,2,3), E. Schaeffner(4), S. Chadban(5), J. Dong(1), C. Rose(1), O. Johnston(1) and J.Gill(1,2) of (1) the Division of Nephrology, The University of British Columbia, Vancouver, British Columbia, Canada, (2) Tufts-New England Medical Centre, Boston, MA, USA, (3) the Centre for Health Evaluation and Outcome Sciences, St. Paul’s Hospital, Vancouver, British Columbia, Canada, (4) Division of Nephrology, Charitie University Medicine, Campus Virchow Klinikum, Berlin, Germany, and (5) the University of Sydney, Sydney, Australia.
Journal: American Journal of Transplantation
As our ESRD population ages, care strategies need to be reassessed to optimize care across the spectrum of our patients. This study sheds light on the risks and benefits of transplantation in patient > 65 year old. Examining outcomes of standard and extended criteria cadaveric transplantation as well as low and intermediate risk living donor transplantation the study demonstrates differences in long term survivial with living donation providing superior outcomes in patients > 65. These data show the need for future research into ways to minimize mortality risk in this population as well as providing important information to inform patients in transplantation decision making.